Trial
NCT05494593
A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
Takeda Development Center Americas, Inc.
Condition
Mucopolysaccharidosis (MPS)
Intervention
ELAPRASE
Why stopped
Study was closed due to enrollment challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-09